| Positive allosteric modulation of cannabinoid receptor type 1 suppresses pathological pain without producing tolerance or dependence RA Slivicki, Z Xu, PM Kulkarni, RG Pertwee, K Mackie, GA Thakur, ... Biological psychiatry 84 (10), 722-733, 2018 | 127 | 2018 |
| Positive Allosteric Modulation of CB1 Cannabinoid Receptor Signaling Enhances Morphine Antinociception and Attenuates Morphine Tolerance Without … RA Slivicki, V Iyer, SS Mali, S Garai, GA Thakur, JD Crystal, AG Hohmann Frontiers in Molecular Neuroscience 13, 54, 2020 | 51 | 2020 |
| A pro-nociceptive phenotype unmasked in mice lacking fatty-acid amide hydrolase LM Carey, RA Slivicki, E Leishman, B Cornett, K Mackie, H Bradshaw, ... Molecular pain 12, 1744806916649192, 2016 | 50 | 2016 |
| Brain-permeant and-impermeant inhibitors of fatty acid amide hydrolase synergize with the opioid analgesic morphine to suppress chemotherapy-induced neuropathic nociception … RA Slivicki, SA Saberi, V Iyer, VK Vemuri, A Makriyannis, AG Hohmann Journal of Pharmacology and Experimental Therapeutics 367 (3), 551-563, 2018 | 37 | 2018 |
| The cannabinoid CB2 receptor agonist LY2828360 synergizes with morphine to suppress neuropathic nociception and attenuates morphine reward and physical dependence V Iyer, RA Slivicki, AC Thomaz, JD Crystal, K Mackie, AG Hohmann European journal of pharmacology 886, 173544, 2020 | 35 | 2020 |
| The chemotherapeutic agent paclitaxel selectively impairs learning while sparing source memory and spatial memory AE Smith, RA Slivicki, AG Hohmann, JD Crystal Behavioural brain research 320, 48-57, 2017 | 29 | 2017 |
| Impact of Genetic Reduction of NMNAT2 on Chemotherapy-Induced Losses in Cell Viability In Vitro and Peripheral Neuropathy In Vivo RA Slivicki, YO Ali, HC Lu, AG Hohmann PloS one 11 (1), e0147620, 2016 | 29 | 2016 |
| Voluntary exercise reduces both chemotherapy-induced neuropathic nociception and deficits in hippocampal cellular proliferation in a mouse model of paclitaxel-induced … RA Slivicki, SS Mali, AG Hohmann Neurobiology of Pain 6, 100035, 2019 | 28 | 2019 |
| Brain permeant and impermeant inhibitors of fatty-acid amide hydrolase suppress the development and maintenance of paclitaxel-induced neuropathic pain without producing … RA Slivicki, Z Xu, SS Mali, AG Hohmann Pharmacological research 142, 267-282, 2019 | 25 | 2019 |
| Oral oxycodone self‐administration leads to features of opioid misuse in male and female mice RA Slivicki, T Earnest, YH Chang, R Pareta, E Casey, JN Li, J Tooley, ... Addiction biology 28 (1), e13253, 2023 | 20 | 2023 |
| Wireless, battery-free implants for electrochemical catecholamine sensing and optogenetic stimulation T Stuart, WJ Jeang, RA Slivicki, BJ Brown, A Burton, VE Brings, ... ACS nano 17 (1), 561-574, 2022 | 20 | 2022 |
| Harmonized cross-species cell atlases of trigeminal and dorsal root ganglia SA Bhuiyan, M Xu, L Yang, E Semizoglou, P Bhatia, KI Pantaleo, ... bioRxiv, 2023 | 10 | 2023 |
| The cannabinoid agonist CB-13 produces peripherally mediated analgesia in mice but elicits tolerance and signs of central nervous system activity with repeated dosing RA Slivicki, J Yi, VE Brings, PN Huynh, RW Gereau IV Pain 163 (8), 1603-1621, 2022 | 5 | 2022 |
| Bradykinin receptor expression and bradykinin-mediated sensitization of human sensory neurons J Yi, Z Bertels, JS Del Rosario, AJ Widman, RA Slivicki, M Payne, ... Pain 165 (1), 202-215, 2024 | 3 | 2024 |
| Sustained depolarization induces homeostatic plasticity in mouse and human sensory neurons JS Del Rosario, LA McIlvried, MY Pullen, A Wangzhou, TD Sheahan, ... The Journal of Pain 23 (5), 6, 2022 | 2 | 2022 |
| Intrinsic Homeostatic Plasticity in Mouse and Human Sensory Neurons LA McIlvried, JS Del Rosario, MY Pullen, A Wangzhou, TD Sheahan, ... bioRxiv, 2023 | 1 | 2023 |
| Bradykinin-mediated sensitization and receptor expression in human sensory neurons J Yi, Z Bertels, J Del Rosario, RA Slivicki, AJ Widman, RW Gereau The Journal of Pain 23 (5), 14, 2022 | 1 | 2022 |
| The cannabinoid agonist CB-13 produces peripherally mediated analgesia in mice but elicits tolerance and signs of CNS activity with repeated dosing RA Slivicki, J Yi, VE Brings, PN Huynh, RW Gereau IV bioRxiv, 2021.04. 23.441212, 2021 | 1 | 2021 |
| Impact of Δ9-Tetrahydrocannabinol and oxycodone co-administration on measures of antinociception, dependence, circadian activity, and reward in mice RA Slivicki, JG Wang, VTT Nhat, AV Kravitz, MC Creed, RW Gereau IV bioRxiv, 2023.12. 04.569809, 2023 | | 2023 |
| Impact of Δ9-Tetrahydrocannabinol Administration on Measures of Oxycodone-induced Antinociception, Dependence and Reward in Mice R Slivicki, VTT Nhat, JG Wang, AV Kravitz, MC Creed, RW Gereau IV The Journal of Pain 23 (5), 19, 2022 | | 2022 |
